Diabetes type 2 management: what are the differences between DPP-4 inhibitors and how do you choose?
Expert Opin Pharmacother
.
2017 Jun;18(9):839-841.
doi: 10.1080/14656566.2017.1323878.
Epub 2017 May 4.
Authors
Kashif M Munir
1
,
Elizabeth M Lamos
1
Affiliation
1
a Department of Medicine, Division of Endocrinology, Diabetes and Nutrition , University of Maryland School of Medicine , Baltimore , MD , USA.
PMID:
28449622
DOI:
10.1080/14656566.2017.1323878
No abstract available
Keywords:
Alogliptin; dipeptidyl peptidase −4 inhibitor; linagliptin; saxagliptin; sitagliptin.